DalsnaFinance › Analyst accuracy › RBC Capital Markets › A target
RBC Capital raises Agilent stock price target on pharma strength
RBC Capital raised its price target on Agilent Technologies Inc. shares (NYSE:A) to $185 from $155 on Wednesday while maintaining an Outperform rating.
A fact about what RBC Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.